Dr. Fernando Recio, MD
What this data tells you about Dr. Recio
Dr. Fernando Recio is a hematology & oncology in Boca Raton, FL, with 20 years in practice. Based on federal Medicare data, Dr. Recio performed 26,169 Medicare services across 2,073 unique beneficiaries.
Between the years covered by Open Payments, Dr. Recio received a total of $25,043 from 43 pharmaceutical and/or device companies across 286 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Recio is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Paclitaxel chemotherapy injection | 16,451 | $0 | $3 |
| Dexamethasone injection (steroid) | 1,150 | $0 | $3 |
| Office visit, established patient (30-39 min) | 1,071 | $97 | $380 |
| Anti-nausea injection (ondansetron/Zofran) | 1,024 | $0 | $3 |
| Infusion, normal saline solution, 250 cc | 888 | $1 | $2 |
| Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 828 | $88 | $400 |
| Injection, carboplatin, 50 mg | 703 | $2 | $40 |
| Blood draw (venipuncture) | 619 | $8 | $25 |
| Complete blood count (CBC) with differential | 446 | $8 | $22 |
| 5% dextrose/water (500 ml = 1 unit) | 397 | $1 | $5 |
| Administration of chemotherapy into vein, each additional hour | 293 | $23 | $110 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 269 | $44 | $142 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 247 | $23 | $80 |
| Administration of chemotherapy into vein, 1 hour or less | 184 | $107 | $440 |
| Injection of additional new drug or substance into vein | 181 | $13 | $72 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 127 | $16 | $92 |
| Injection, diphenhydramine hcl, up to 50 mg | 124 | $1 | $8 |
| Administration of additional new drug or substance into vein, 1 hour or less | 120 | $53 | $200 |
| Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | 111 | $97 | $407 |
| Exam of vagina and cervix using an endoscope | 108 | $108 | $383 |
| Exam of external female genitals using an endoscope | 105 | $103 | $480 |
| Exam of cervix and upper part of vagina using an endoscope | 105 | $104 | $362 |
| New patient office visit (45-59 min) | 104 | $131 | $516 |
| Irrigation of implanted venous access drug delivery device | 83 | $18 | $81 |
| Application of on-body injector for under skin injection | 69 | $15 | $85 |
| Urinalysis, manual | 61 | $3 | $90 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 53 | $18 | $60 |
| Release of scar tissue at ureter | 50 | $1,208 | $4,200 |
| Repair of vaginal defect using an endoscope | 42 | $404 | $3,600 |
| Complete ultrasound scan of pelvis | 42 | $86 | $403 |
| Initial hospital admission, high complexity | 20 | $137 | $580 |
| Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, more than 250.0 g | 19 | $520 | $5,200 |
| Biopsy of lining of uterus and/or removal of polyp using an endoscope | 17 | $1,109 | $2,000 |
| Removal of uterus, cervix, and lymph nodes of pelvis with biopsy of aortic lymph node using an endoscope | 16 | $1,634 | $6,000 |
| Office visit, established patient (20-29 min) | 16 | $75 | $190 |
| Removal or destruction of cysts or growths of abdominal cavity, 5.1 to 10.0 cm | 13 | $674 | $5,000 |
| Exam and biopsy of external female genitals using an endoscope | 13 | $138 | $566 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (38%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.
Geographic Context
4.1 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Recio is a mixed practice specialist, with above-average Medicare volume (top 21% in FL), and mixed engagement industry engagement, with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Recio experienced with paclitaxel chemotherapy injection?
Does Dr. Recio receive payments from pharmaceutical companies?
How do Dr. Recio's costs compare to other hematology & oncologys in Boca Raton?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology